Postoperative Nausea and Vomiting in Female Patients Undergoing Breast and Gynecological Surgery: A Narrative Review of Risk Factors and Prophylaxis

Marco Echeverria-Villalobos, Juan Fiorda-Diaz, Alberto Uribe, Sergio D Bergese, Marco Echeverria-Villalobos, Juan Fiorda-Diaz, Alberto Uribe, Sergio D Bergese

Abstract

Postoperative nausea and vomiting (PONV) have been widely studied as a multifactorial entity, being of female gender the strongest risk factor. Reported PONV incidence in female surgical populations is extremely variable among randomized clinical trials. In this narrative review, we intend to summarize the incidence, independent predictors, pharmacological and non-pharmacological interventions for PONV reported in recently published clinical trials carried out in female patients undergoing breast and gynecologic surgery, as well as the implications of the anesthetic agents on the incidence of PONV. A literature search of manuscripts describing PONV management in female surgical populations (breast surgery and gynecologic surgery) was carried out in PubMed, MEDLINE, and Embase databases. Postoperative nausea and vomiting incidence were highly variable in patients receiving placebo or no prophylaxis among RCTs whereas consistent results were observed in patients receiving 1 or 2 prophylactic interventions for PONV. Despite efforts made, a considerable number of female patients still experienced significant PONV. It is critical for the anesthesia provider to be aware that the coexistence of independent risk factors such as the level of sex hormones (pre- and postmenopausal), preoperative anxiety or depression, pharmacogenomic pleomorphisms, and ethnicity further enhances the probability of experiencing PONV in female patients. Future RCTs should closely assess the overall risk of PONV in female patients considering patient- and surgery-related factors, and the level of compliance with current guidelines for prevention and management of PONV.

Keywords: breast surgery; female gender; gynecological surgery; postoperative nausea and vomiting; randomized clinical trial ERAS (Enhance Recovery After Surgery).

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Echeverria-Villalobos, Fiorda-Diaz, Uribe and Bergese.

Figures

Figure 1
Figure 1
Flow diagram summarizing the selection of randomized clinical trials (RCTs) describing postoperative nausea and vomiting (PONV) in female surgical population.

References

    1. Pierre S, Benais H, Pouymayou J. Apfel's simplified score may favourably predict the risk of postoperative nausea and vomiting. Can J Anaesth. (2002) 49:237. 10.1007/BF03020521
    1. Apfel C, Heidrich F, Jukar-Rao S, Jalota L, Hornuss C, Whelan R, et al. . Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. (2012) 109:742–53. 10.1093/bja/aes276
    1. Smith CA, Ruth-Sahd L. Reducing the incidence of postoperative nausea and vomiting begins with risk screening: an evaluation of the evidence. J Perianesth Nurs. (2016) 31:158–71. 10.1016/j.jopan.2015.03.011
    1. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. . Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. (2019) 131:411–48. 10.1213/ANE.0000000000004833
    1. Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. . Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. (2014) 118:85–113. 10.1213/ANE.0000000000000002
    1. Conti D, Ballo P, Boccalini R, Boccherini A, Cantini S, Venni A, et al. . The effect of patient sex on the incidence of early adverse events in a population of elderly patients. Anaesth Intensive Care. (2014) 42:455–9. 10.1177/0310057X1404200405
    1. Lee J-W, Kim S-K, Kim D-C, Han YJ, Ko S-H. The effects of female hormones on postoperative nausea and vomiting. Korean J Anesthesiol. (2008) 54:58–62. 10.4097/kjae.2008.54.1.58
    1. Panditrao AM, Panditrao MM, Panditrao MM, Azher I. A prospective study to compare the incidence of post-operative nausea, vomiting (PONV) in female patients undergoing surgical procedures under general anaesthesia during proliferative and secretory phase of menstrual cycle. Int J Students' Res. (2011) 1:51–6. 10.5549/IJSR.1.2.51-56
    1. Šimurina T, Mraovic B, Skitarelić N, Andabaka T, Sonicki Z. Influence of the menstrual cycle on the incidence of nausea and vomiting after laparoscopic gynecological surgery: a pilot study. J Clin Anesth. (2012) 24:185–92. 10.1016/j.jclinane.2011.07.011
    1. Matchock RL, Levine ME, Gianaros PJ, Stern RM. Susceptibility to nausea and motion sickness as a function of the menstrual cycle. Women's Health Issues. (2008) 18:328–35. 10.1016/j.whi.2008.01.006
    1. Lee JW, Lee JS, Kim JH, Kim YJ, Woo JH, Kim DY, et al. . Influence of the phase of menstrual cycle on postoperative nausea and vomiting after breast cancer surgery. Ewha Medical J. (2018) 41:19–23. 10.12771/emj.2018.41.1.19
    1. Deshpande S, van Asselt A, Tomini F, Armstrong N, Allen A, Noake C, et al. . Preferred reporting items for systematic reviews and meta-analysis (PRISMA) checklist. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. NIHR Journals Library. (2013).
    1. D'souza N, Swami M, Bhagwat S. Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery. Int J Gynaecol Obstet. (2011) 113:124–7. 10.1016/j.ijgo.2010.11.022
    1. Ekinci O, Malat I, Işitmangil G, Aydin N. A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting. Gynecol Obstet Invest. (2011) 71:59–65. 10.1159/000320747
    1. Park S, Cho E. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res. (2011) 39:399–407. 10.1177/147323001103900207
    1. Park S, Cho EJ. A randomized controlled trial of two different interventions for the prevention of postoperative nausea and vomiting: total intravenous anaesthesia using propofol and remifentanil versus prophylactic palonosetron with inhalational anaesthesia using sevoflurane-nitrous oxide. J Int Med Res. (2011) 39:1808–15. 10.1177/147323001103900523
    1. Kasagi Y, Hayashida M, Sugasawa Y, Kikuchi I, Yamaguchi K, Okutani R, et al. . Antiemetic effect of naloxone in combination with dexamethasone and droperidol in patients undergoing laparoscopic gynecological surgery. J Anesth. (2013) 27:879–84. 10.1007/s00540-013-1630-8
    1. Kawano H, Ohshita N, Katome K, Kadota T, Kinoshita M, Matsuoka Y, et al. . Effects of a novel method of anesthesia combining propofol and volatile anesthesia on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery. Braz J Anesthesiol. (2016) 66:12–8. 10.1016/j.bjane.2014.07.005
    1. Soga T, Kume K, Kakuta N, Hamaguchi E, Tsutsumi R, Kawanishi R, et al. . Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study. J Anesth. (2015) 29:696–701. 10.1007/s00540-015-2006-z
    1. Joo J, Park YG, Baek J, Moon YE. Haloperidol dose combined with dexamethasone for PONV prophylaxis in high-risk patients undergoing gynecological laparoscopic surgery: a prospective, randomized, double-blind, dose-response and placebo-controlled study. BMC Anesthesiol. (2015) 15:99. 10.1186/s12871-015-0081-1
    1. Yang X-Y, Xiao J, Chen Y-H, Wang Z-T, Wang H-L, He D-H, et al. . Dexamethasone alone vs in combination with transcutaneous electrical acupoint stimulation or tropisetron for prevention of postoperative nausea and vomiting in gynaecological patients undergoing laparoscopic surgery. BJA. (2015) 115:883–9. 10.1093/bja/aev352
    1. Bang Y-S, Kim YU, Oh D, Shin EY, Park SK. A randomized, double-blind trial evaluating the efficacy of palonosetron with total intravenous anesthesia using propofol and remifentanil for the prevention of postoperative nausea and vomiting after gynecologic surgery. J Anesth. (2016) 30:935–40. 10.1007/s00540-016-2249-3
    1. Dewinter G, Teunkens A, Vermeulen K, Devroe S, Van Hemelrijck J, Meuleman C, et al. . Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: a double-blind, randomised, placebo-controlled noninferiority study. EJA. (2016) 33:96–103. 10.1097/EJA.0000000000000288
    1. Geng Z-Y, Liu Y-F, Wang S-S, Wang D-X. Intra-operative dexmedetomidine reduces early postoperative nausea but not vomiting in adult patients after gynaecological laparoscopic surgery: a randomised controlled trial. EJA. (2016) 33:761–6. 10.1097/EJA.0000000000000491
    1. Lee S-H, Kim J-D, Park S-A, Oh C-S, Kim S-H. Effects of μ-Opioid receptor gene polymorphism on postoperative nausea and vomiting in patients undergoing general anesthesia with remifentanil: double blinded randomized trial. J Korean Med Sci. (2015) 30:651–7. 10.3346/jkms.2015.30.5.651
    1. Kim SH, Oh CS, Lee SJ. Efficacy of palonosetron and ramosetron on postoperative nausea and vomiting related to intravenous patient-controlled analgesia with opioids after gynecological laparoscopic surgery (double-blinded prospective randomized controlled trial). J Anesth. (2015) 29:585–92. 10.1007/s00540-015-1981-4
    1. Oh CS, Jung E, Lee SJ, Kim SH. Effect of nefopam- versus fentanyl-based patient-controlled analgesia on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: a prospective double-blind randomized controlled trial. Curr Med Res Opin. (2015) 31:1599–607. 10.1185/03007995.2015.1058251
    1. Bhakta P, Ghosh BR, Singh U, Govind PS, Gupta A, Kapoor KS, et al. . Incidence of postoperative nausea and vomiting following gynecological laparoscopy: A comparison of standard anesthetic technique and propofol infusion. Acta Anaesthesiologica Taiwanica. (2016) 54:108–13. 10.1016/j.aat.2016.10.002
    1. Khan MA, Siddiqi KJ, Khan MS. Prophylactic use of gabapentin to reduce postoperative nausea and vomiting in patients undergoing diagnostic gynecological laparoscopy. Anaesth Pain Intensive Care. (2017) 21:19–24.
    1. Seki H, Furumoto K, Sato M, Kagoya A, Hashimoto H, Sekiguchi Y, et al. . Effects of epidural anesthesia on postoperative nausea and vomiting in laparoscopic gynecological surgery: a randomized controlled trial. J Anesth. (2018) 32:608–15. 10.1007/s00540-018-2525-5
    1. Omran HASA, Nasr DAM. Effect of premedication with mirtazapine versus ondansetron on postoperative nausea and vomiting in breast surgery. Egpt J Anesth. (2011) 27:135–9. 10.1016/j.egja.2011.06.003
    1. Voigt M, Fröhlich CW, Waschke KF, Lenz C, Göbel U, Kerger H. Prophylaxis of postoperative nausea and vomiting in elective breast surgery. J Clin Anesth. (2011) 23:461–8. 10.1016/j.jclinane.2011.01.005
    1. Olanders KJ, Lundgren GA, Johansson AM. Betamethasone in prevention of postoperative nausea and vomiting following breast surgery. J Clin Anesth. (2014) 26:461–5. 10.1016/j.jclinane.2014.02.006
    1. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. (1999) 91:693–700. 10.1097/00000542-199909000-00022
    1. Koivuranta M, Läärä E, Snåre L, Alahuhta S. A survey of postoperative nausea and vomiting. Anaesthe. (1997) 52:443–9. 10.1111/j.1365-2044.1997.117-az0113.x
    1. Krieser KA, Riley III JB, Baus JE, Hoffman JT, Sullivan JN. PONV Prophylaxis failure disproportionately affects female patients, despite intraoperative computerized decision support guidance. Graduate Med Edu Res J. (2020) 2:6. 10.32873/unmc.dc.gmerj.2.1.091
    1. Tabrizi S, Malhotra V, Turnbull ZA, Goode V. Implementation of postoperative nausea and vomiting guidelines for female adult patients undergoing anesthesia during gynecologic and breast surgery in an ambulatory setting. J Perianesth Nurs. (2019) 34:851–60. 10.1016/j.jopan.2018.10.006
    1. Cohen MM, Duncan PG, DeBoer DP, Tweed WA. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg. (1994) 78:7–16. 10.1213/00000539-199401000-00004
    1. Reihner E, Grunditz R, Giesecke K, Gustafsson L. Postoperative nausea and vomiting after breast surgery: efficacy of prophylactic ondansetron and droperidol in a randomized placebo-controlled study. Eur J Anaesthesiol. (2000) 17:197–203. 10.1097/00003643-200003000-00012
    1. Layeeque R, Siegel E, Kass R, Henry-Tillman RS, Colvert M, Mancino A, et al. . Prevention of nausea and vomiting following breast surgery. Am J Surg. (2006) 191:767–72. 10.1016/j.amjsurg.2005.07.040
    1. ODDBY–MUHRBECK E, Jakobsson J, Andersson L, Askergren J. Postoperative nausea and vomiting. A comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiologica Scandinavica. (1994) 38:52–6. 10.1111/j.1399-6576.1994.tb03837.x
    1. Hammas B, Thörn SE, Wattwil M. Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen–comparison with propofol or placebo. Acta Anaesthesiol Scand. (2002) 46:232–7. 10.1034/j.1399-6576.2002.460302.x
    1. Wattwil M, Thörn SE, Lövqvist Å, Wattwil L, Gupta A, Liljegren G. Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand. (2003) 47:823–7. 10.1034/j.1399-6576.2003.00172.x
    1. Read M, James M. Immediate postoperative complications following gynaecological surgery. Obstetrician Gynaecologist. (2002) 4:29–35. 10.1576/toag.2002.4.1.29
    1. Tseng L-H, Liou S-C, Chang T-C, Tsai S-C, Soong Y-K, Wong S-Y, et al. . Randomized blinded study of the incidence of postoperative nausea and vomiting in women after major gynecologic laparoscopic surgery. J Minim Invasive Gynecol. (2006) 13:413–7. 10.1016/j.jmig.2006.05.003
    1. Harmon D, Ryan M, Kelly A, Bowen M. Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. Br J Anaesth. (2000) 84:463–7. 10.1093/oxfordjournals.bja.a013471
    1. Wesmiller SW, Bender CM, Sereika SM, Ahrendt G, Bonaventura M, Bovbjerg DH, et al. . Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery. Oncol Nurs Forum. (2014) 41:195–202. 10.1188/14.ONF.195-202
    1. Pataky A, Kitz D, Andrews R, Lecky J. Nausea and vomiting following ambulatory surgery: are all procedures created equal? Anesth Analg. (1988) 67:163. 10.1213/00000539-198802001-00163
    1. Beattie WS, Lindblad T, Buckley DN, Forrest JB. The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesthesia. (1991) 38:298–302. 10.1007/BF03007618
    1. Zou L, Miao S, Wang L, Wang G. Effects of menstrual cycle on nausea and vomiting after general anesthesia. J Anesth. (2020) 34:519–26. 10.1007/s00540-020-02781-z
    1. Eberhart L, Morin A, Georgieff M. The menstruation cycle in the postoperative phase. its effect of the incidence of nausea and vomiting. Anaesthesist. (2000) 49:532–5. 10.1007/s001010070095
    1. Kudach C, Dunwoody C, Wesmiller S. The relationship of age and postoperative pain in women after surgery for breast cancer. Pain Manag Nurs. (2018) 19:348–53. 10.1016/j.pmn.2017.12.002
    1. Medina-Diaz-Cortés G, Brancaccio-Pérez IV, Esparza-Estrada I, Barbosa-Camacho FJ, Fuentes-Orozco C, González-Hernández PG, et al. . Differences in postoperative pain, nausea, and vomiting after elective laparoscopic cholecystectomy in premenopausal and postmenopausal mexican women. World J Surg. (2022) 46:356–61. 10.1007/s00268-021-06367-y
    1. Kakugawa Y, Minami Y, Tateno H, Inoue H, Fujiya T. Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer. Breast Cancer. (2007) 14:269–76. 10.2325/jbcs.14.269
    1. Bakshi SG, Jibhkate B, Sareen R, Badwe R. Nausea and vomiting after breast cancer surgery, and relationship with tumor receptor status. J Anesth. (2012) 26:187–95. 10.1007/s00540-011-1274-5
    1. Montgomery GH, Schnur JB, Erblich J, Diefenbach MA, Bovbjerg DH. Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery. J Pain Symptom Manage. (2010) 39:1043–52. 10.1016/j.jpainsymman.2009.11.318
    1. Montgomery GH, Bovbjerg DH. Presurgery distress and specific response expectancies predict postsurgery outcomes in surgery patients confronting breast cancer. Health Psychol. (2004) 23:381. 10.1037/0278-6133.23.4.381
    1. Schnur JB, Montgomery GH, Hallquist MN, Goldfarb AB, Silverstein JH, Weltz CR, et al. . Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. Int J Behav Med. (2008) 15:21–8. 10.1007/BF03003070
    1. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol. (1985) 40:1189. 10.1037/0003-066X.40.11.1189
    1. Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, et al. . Cancer patients' expectations of experiencing treatment-related side effects: a university of rochester cancer center-community clinical oncology program study of 938 patients from community practices. Cancer. (2004) 101:851–7. 10.1002/cncr.20423
    1. da Silva H, Sousa A, Guimarães G, Slullitel A, Ashmawi H. Does previous chemotherapy-induced nausea and vomiting predict postoperative nausea and vomiting? Acta Anaesthesiol Scand. (2015) 59:1145–53. 10.1111/aas.12552
    1. Oddby-Muhrbeck E, Öbrink E, Eksborg S, Rotstein S, Lönnqvist P. Is there an association between PONV and chemotherapy-induced nausea and vomiting? Acta Anaesthesiol Scand. (2013) 57:749–53. 10.1111/aas.12053
    1. Fasching P, Kollmannsberger B, Strissel P, Niesler B, Engel J, Kreis H, et al. . Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. J Cancer Res Clin Oncol. (2008) 134:1079–86. 10.1007/s00432-008-0387-1
    1. Rueffert H, Thieme V, Wallenborn J, Lemnitz N, Bergmann A, Rudlof K, et al. . Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting? Anesth Analg. (2009) 109:1442–7. 10.1213/ane.0b013e3181b2359b
    1. Zhang W, Yuan J, Kan Q, Zhang L, Chang Y, Wang Z. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia. Minerva Anestesiol. (2011) 77:33–9.
    1. Wesmiller SW, Henker RA, Sereika SM, Donovan HS, Meng L, Gruen GS, et al. . The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients. Biol Res Nurs. (2013) 15:382–9. 10.1177/1099800412449181
    1. Duncan NW, Wiebking C, Tiret B, Marjańska M, Hayes DJ, Lyttleton O, et al. . Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans. PLoS ONE. (2013) 8:e60312. 10.1371/journal.pone.0060312
    1. Laugsand EA, Fladvad T, Skorpen F, Maltoni M, Kaasa S, Fayers P, et al. . Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. Eur J Cancer. (2011) 47:1682–91. 10.1016/j.ejca.2011.04.014
    1. Wesmiller SW, Sereika SM, Bender CM, Bovbjerg D, Ahrendt G, Bonaventura M, et al. . Exploring the multifactorial nature of postoperative nausea and vomiting in women following surgery for breast cancer. Autonomic Neurosci. (2017) 202:102–7. 10.1016/j.autneu.2016.09.017
    1. Candiotti KA, Yang Z, Buric D, Arheart K, Zhang Y, Rodriguez Y, et al. . Catechol-o-methyltransferase polymorphisms predict opioid consumption in postoperative pain. Anesth Analg. (2014) 119:1194–200. 10.1213/ANE.0000000000000411
    1. Zubieta J-K. Mu Opioid Receptor Genetic Variation and Heroin Addiction. Biol Psychiatry. (2015) 78:439–40. 10.1016/j.biopsych.2015.08.002
    1. Ugochukwu O, Adaobi A, Ewah R, Obioma O. Postoperative nausea and vomiting in a gynecological and obstetrical population in South Eastern Nigeria. Pan Afr Med J. (2010) 7:6. 10.4314/pamj.v7i1.69111
    1. Rodseth RN, Gopalan PD, Cassimjee HM, Goga S. Reduced incidence of postoperative nausea and vomiting in black South Africans and its utility for a modified risk scoring system. Anesth Analg. (2010) 110:1591–4. 10.1213/ANE.0b013e3181da9005
    1. Alli A, Omar S, Tsang S, Naik B. The effect of ethnicity on the incidence of postoperative nausea and vomiting in moderate to high risk patients undergoing general anesthesia in South Africa: a controlled observational study. Middle East J Anaesthesiol. (2017) 24:119.
    1. White PF, Sacan O, Nuangchamnong N, Sun T, Eng MR. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesth Analg. (2008) 107:459–63. 10.1213/ane.0b013e31817aa6e4
    1. Elvir-Lazo OL, White PF, Yumul R, Eng HC. Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review. F1000Res. (2020) 9:F1000. 10.12688/f1000research.21832.1
    1. Ormel G, Romundstad L, Lambert-Jensen P, Stubhaug A. Dexamethasone has additive effect when combined with ondansetron and droperidol for treatment of established PONV. Acta Anaesthesiol Scand. (2011) 55:1196–205. 10.1111/j.1399-6576.2011.02536.x
    1. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, et al. . Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg. (2007) 105:1615–28. 10.1213/01.ane.0000295230.55439.f4
    1. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anesth. (2004) 51:326–41. 10.1007/BF03018236
    1. Lee B, Kim K, Suh DH, Shin H-J, No JH, Lee JR, et al. . Efficacy of single-dose and 2-dose intravenous administration of ramosetron in preventing postoperative nausea and vomiting after laparoscopic gynecologic operation: A randomized, double-blind, placebo-controlled, phase 2 trial. Surg Laparosc Endosc Percutan Tech. (2017) 27:183–8. 10.1097/SLE.0000000000000399
    1. Hong J-M, Han Y-H, Lee D, Hwang BY, Baik J, Cho AR, et al. . Comparison of efficacy between palonosetron-midazolam combination and palonosetron alone for prevention of postoperative nausea and vomiting in patients undergoing breast surgery and patient controlled analgesia: a prospective, randomized, double-blind study: A CONSORT-compliant study. Medicine. (2021) 100:26438. 10.1097/MD.0000000000026438
    1. Kim DS, Koo GH, Kang H, Baek CW, Jung YH, Woo YC, et al. . The antiemetic effect of midazolam or/and ondansetron added to intravenous patient controlled analgesia in patients of pelviscopic surgery. Korean J Anesthesiol. (2012) 62:343. 10.4097/kjae.2012.62.4.343
    1. Stoltz R, Parisi S, Shah A, Macciocchi A. Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers. Biopharm Drug Dispos. (2004) 25:329–37. 10.1002/bdd.410
    1. Liu M, Zhang H, Du B-X, Xu F-Y, Zou Z, Sui B, et al. . Neurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysis. Medicine. (2015) 94:e762. 10.1097/MD.0000000000000762
    1. Gesztesi Z, Scuderi PE, White PF, Wright W, Wender RH, D'Angelo R, et al. . Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology. (2000) 93:931–7. 10.1097/00000542-200010000-00009
    1. Ham SY, Shim YH, Kim EH, Son MJ, Park WS, Lee JS. Aprepitant for antiemesis after laparoscopic gynaecological surgery: a randomised controlled trial. EJA. (2016) 33:90–5. 10.1097/EJA.0000000000000242
    1. Huh B, Jung S, White W, Jeon Y. Anti-emetic effect of midazolam added to morphine patient-controlled analgesia after total abdominal hysterectomy. Anaesth Intensive Care. (2010) 38:481–5. 10.1177/0310057X1003800311
    1. Ross JE, Vertosick E, Long M, Cansino C, Assel M, Twersky R. Midazolam's effect on post operative nausea and vomiting and discharge times in outpatients undergoing cancer related surgery. AANA J. (2019) 87:179.
    1. Grant MC, Kim J, Page AJ, Hobson D, Wick E, Wu CL. The effect of intravenous midazolam on postoperative nausea and vomiting: a meta-analysis. Anesthe Analg. (2016) 122:656–63. 10.1213/ANE.0000000000000941
    1. Ahn EJ, Kang H, Choi GJ, Baek CW, Jung YH, Woo YC. The Effectiveness of Midazolam for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis. Anesth Analg. (2016) 122:664–76. 10.1213/ANE.0000000000001062
    1. Rodola F. Midazolam as an anti-emetic. Eur Rev Med Pharmacol Sci. (2006) 10:121.
    1. Florio TD. The use of midazolam for persistent postoperative nausea and vomiting. Anaesth Intensive Care. (1992) 20:383–6. 10.1177/0310057X9202000324
    1. Racke K, Reimann A, Schwörer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res. (1995) 73:83–7. 10.1016/0166-4328(96)00075-7
    1. Kamali A, Beigi S, Shokrpour M, Pazuki S. The efficacy of ginger and doxedetomidine in reducing postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Altern Ther Health Med. (2020) 26:28–33.
    1. Gu J. Wang G-n, Li M-m. Clinical observation of HANS for the prevention of postoperative nausea and vomiting after modified radical mastectomy Heilongjiang. Med J. (2009) 33:604–6.
    1. Alcaraz R, Monerris M, Jiménez-Capel Y, Moret E, Janeiro M, Vila P. Effectiveness and safety of continuous stimulation without needles with STIPER® puncture in the prophylaxis of postoperative nausea and vomiting in elective breast surgery: 1AP7-6. (EJA). (2014) 31:23. 10.1097/00003643-201406001-00065
    1. Sun R, Dai W, Liu Y, Liu C, Liu Y, Gong Y, et al. . Non-needle acupoint stimulation for prevention of nausea and vomiting after breast surgery: a meta-analysis. Medicine. (2019) 9:14713. 10.1097/MD.0000000000014713
    1. Ao L, Shi J, Bai Y, Zhang S, Gan J. Effects of transcutaneous electrical acupoint stimulation on perioperative immune function and postoperative analgesia in patients undergoing radical mastectomy: a randomized controlled trial. Exp Ther Med. (2021) 21:1. 10.3892/etm.2021.9615
    1. Küçük E, Bülbül T. The effects of acupressure on nausea, vomiting, and vital signs in patients undergoing gynecologic surgery: a randomized controlled trial. J Perianesth Nurs. (2021). 10.1016/j.jopan.2020.10.017
    1. Apfel C, Kranke P, Katz M, Goepfert C, Papenfuss T, Rauch S, et al. . Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. (2002) 88:659–68. 10.1093/bja/88.5.659
    1. Morita T, Yamamoto M, Sakamoto A. What are the factors affecting postoperative nausea and vomiting following breast cancer surgery with inhalation anesthesia? JNMS. (2020) 88:418–22. 10.1272/jnms.JNMS.2021_88-510
    1. Kwak H, Chang YJ, Lee KC, Jung WS, Kwon S, Jo YY. Antiemetic efficacy of dexmedetomidine versus dexmedetomidine-dexamethasone combination in patients undergoing breast surgery. J IntMed Res. (2019) 47:5060–9. 10.1177/0300060519872031
    1. Hopwood S, Stamford J. Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via α1 and α2A adrenoceptors. Neuropharmacol. (2001) 41:433–42. 10.1016/S0028-3908(01)00087-9
    1. Whittington RA, Virág L. Dexmedetomidine-induced decreases in accumbal dopamine in the rat are partly mediated via the locus coeruleus. Anesth Analge. (2006) 102:448–55. 10.1213/01.ane.0000195234.07413.5a
    1. Yang D, Hong JH. Dexmedetomidine modulates histamine-induced Ca2+ signaling and pro-inflammatory cytokine expression. Korean J Physiol Pharmacol. (2015) 19:413–20. 10.4196/kjpp.2015.19.5.413
    1. Dumestre DO, Webb CE, Temple-Oberle C. Improved recovery experience achieved for women undergoing implant-based breast reconstruction using an enhanced recovery after surgery model. Plast Reconstr Surg. (2017) 139:550–9. 10.1097/PRS.0000000000003056
    1. Chiu C, Aleshi P, Esserman LJ, Inglis-Arkell C, Yap E, Whitlock EL, et al. . Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol. (2018) 18:41. 10.1186/s12871-018-0505-9
    1. Temple-Oberle C, Shea-Budgell MA, Tan M, Semple JL, Schrag C, Barreto M, et al. . Consensus review of optimal perioperative care in breast reconstruction: enhanced recovery after surgery (ERAS) society recommendations. Plast Reconstr Surg. (2017) 139:1056e-71e. 10.1097/PRS.0000000000003242
    1. Astanehe A, Temple-Oberle C, Nielsen M, de Haas W, Lindsay R, Matthews J, et al. . An enhanced recovery after surgery pathway for microvascular breast reconstruction is safe and effective. Prs-Glob Open. (2018) 6:1634. 10.1097/GOX.0000000000001634
    1. Tripathy S, Mandal I, Rao PB, Panda A, Mishra T, Kar M. Opioid-free anesthesia for breast cancer surgery: a comparison of ultrasound guided paravertebral and pectoral nerve blocks. a randomized controlled trial. J Anaesthesiol Clin Pharmacol. (2019) 35:475. 10.4103/joacp.JOACP_364_18
    1. Kim Y, Oh C, Youn S, Yun S, Park H, Lee W, et al. . Thoracic interfascial plane block for multimodal analgesia after breast lumpectomy. Anesth Pain Med. (2019) 14:222–9. 10.17085/apm.2019.14.2.222
    1. Khemka R, Chakrborty A, Agrawal S, Ahmed R. Is COMBIPECS the answer to perioperative analgesia for breast surgery? a double blinded randomized controlled trial. Indian J Anaesth. (2019) 63:530. 10.4103/ija.IJA_222_19
    1. Bell A, Ali O, Robinson A, Aggarwal A, Blundell M, Townend A, et al. . The role of pectoral nerve blocks in a day-case mastectomy service: a prospective cohort study. Ann Med Surg. (2019) 48:65–8. 10.1016/j.amsu.2019.10.019
    1. Huang W, Wang W, Xie W, Chen Z, Liu Y. Erector spinae plane block for postoperative analgesia in breast and thoracic surgery: a systematic review and meta-analysis. J Clin Anesth. (2020) 66:109900. 10.1016/j.jclinane.2020.109900

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi